Nieto, Y., Gruschkus, S., Valdez, B. C., Jones, R. B., Anderlini, P., Hosing, C., Popat, U., Qazilbash, M., Kebriaei, P., Alousi, A., Saini, N., Srour, S., Rezvani, K., Ramdial, J., Barnett, M., Gulbis, A., Shigle, T. L., Ahmed, S., Iyer, S., Lee, H., Nair, R., Parmar, S., Steiner, R., Dabaja, B., Pinnix, C., Gunther, J., Cuglievan, B., Mahadeo, K., Khazal, S., Chuang, H., Champlin, R., Shpall, E. J. and Andersson, B. S. (2021) “Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis”, Haematologica. Pavia, Italy, 107(4), pp. 899-908. doi: 10.3324/haematol.2021.278311.